Tokyo, Japan

Teruki Kobayashi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruki Kobayashi. Retrieved from https://idiyas.com/inventor/teruki-kobayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teruki Kobayashi: Innovator in Pharmaceutical Chemistry

Introduction

Teruki Kobayashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of nitrogen-containing heterocyclic compounds. His work has implications for the treatment of various urinary disorders.

Latest Patents

Kobayashi holds a patent for nitrogen-containing heterocyclic compounds. These compounds are represented by a specific formula and exhibit strong EP1 antagonistic activity when administered to humans or animals. They are particularly useful as effective components in pharmaceutical agents aimed at preventing and treating overactive bladder symptoms, including frequent urination, urinary urgency, and urinary incontinence.

Career Highlights

Kobayashi is associated with Asahi Kasei Pharma Corporation, where he has been instrumental in advancing pharmaceutical research. His innovative work has led to the development of new therapeutic options for patients suffering from urinary disorders.

Collaborations

He has collaborated with notable colleagues such as Masakazu Atobe and Kenji Naganuma, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Teruki Kobayashi's contributions to pharmaceutical chemistry, particularly through his patent on nitrogen-containing heterocyclic compounds, highlight his role as a key innovator in the field. His work continues to impact the development of effective treatments for urinary disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…